These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 33584989)

  • 1. Integrative analysis of layers of data in hepatocellular carcinoma reveals pathway dependencies.
    Bhat M; Pasini E; Pastrello C; Rahmati S; Angeli M; Kotlyar M; Ghanekar A; Jurisica I
    World J Hepatol; 2021 Jan; 13(1):94-108. PubMed ID: 33584989
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Epigenetic basis of hepatocellular carcinoma: A network-based integrative meta-analysis.
    Bhat V; Srinathan S; Pasini E; Angeli M; Chen E; Baciu C; Bhat M
    World J Hepatol; 2018 Jan; 10(1):155-165. PubMed ID: 29399289
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Transcriptomic Analysis of Chronic Hepatitis B and C and Liver Cancer Reveals MicroRNA-Mediated Control of Cholesterol Synthesis Programs.
    Selitsky SR; Dinh TA; Toth CL; Kurtz CL; Honda M; Struck BR; Kaneko S; Vickers KC; Lemon SM; Sethupathy P
    mBio; 2015 Dec; 6(6):e01500-15. PubMed ID: 26646011
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Construction of a Comprehensive Multiomics Map of Hepatocellular Carcinoma and Screening of Possible Driver Genes.
    Liu Z; Lin Y; Gao X; Mai R; Piao X; Ye J; Liang R
    Front Genet; 2020; 11():634. PubMed ID: 32670354
    [No Abstract]   [Full Text] [Related]  

  • 5. Comprehensive analysis of microRNA-regulated protein interaction network reveals the tumor suppressive role of microRNA-149 in human hepatocellular carcinoma via targeting AKT-mTOR pathway.
    Zhang Y; Guo X; Xiong L; Yu L; Li Z; Guo Q; Li Z; Li B; Lin N
    Mol Cancer; 2014 Nov; 13():253. PubMed ID: 25424347
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Identification of potential miRNA-mRNA regulatory network contributing to pathogenesis of HBV-related HCC.
    Lou W; Liu J; Ding B; Chen D; Xu L; Ding J; Jiang D; Zhou L; Zheng S; Fan W
    J Transl Med; 2019 Jan; 17(1):7. PubMed ID: 30602391
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Analysis of microarrays of miR-34a and its identification of prospective target gene signature in hepatocellular carcinoma.
    Ren FH; Yang H; He RQ; Lu JN; Lin XG; Liang HW; Dang YW; Feng ZB; Chen G; Luo DZ
    BMC Cancer; 2018 Jan; 18(1):12. PubMed ID: 29298665
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The identification of key genes and pathways in hepatocellular carcinoma by bioinformatics analysis of high-throughput data.
    Zhang C; Peng L; Zhang Y; Liu Z; Li W; Chen S; Li G
    Med Oncol; 2017 Jun; 34(6):101. PubMed ID: 28432618
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Aberrantly DNA Methylated-Differentially Expressed Genes and Pathways in Hepatocellular Carcinoma.
    Cai C; Wang W; Tu Z
    J Cancer; 2019; 10(2):355-366. PubMed ID: 30719129
    [No Abstract]   [Full Text] [Related]  

  • 10. HCCDB: A Database of Hepatocellular Carcinoma Expression Atlas.
    Lian Q; Wang S; Zhang G; Wang D; Luo G; Tang J; Chen L; Gu J
    Genomics Proteomics Bioinformatics; 2018 Aug; 16(4):269-275. PubMed ID: 30266410
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Identifying hub genes and dysregulated pathways in hepatocellular carcinoma.
    Jin B; Wang W; Du G; Huang GZ; Han LT; Tang ZY; Fan DG; Li J; Zhang SZ
    Eur Rev Med Pharmacol Sci; 2015 Feb; 19(4):592-601. PubMed ID: 25753876
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Identification of survival-related predictors in hepatocellular carcinoma through integrated genomic, transcriptomic, and proteomic analyses.
    Dong F; Yang Q; Wu Z; Hu X; Shi D; Feng M; Li J; Zhu L; Jiang S; Bao Z
    Biomed Pharmacother; 2019 Jun; 114():108856. PubMed ID: 30981109
    [TBL] [Abstract][Full Text] [Related]  

  • 13. DNA methylation-driven genes for constructing diagnostic, prognostic, and recurrence models for hepatocellular carcinoma.
    Long J; Chen P; Lin J; Bai Y; Yang X; Bian J; Lin Y; Wang D; Yang X; Zheng Y; Sang X; Zhao H
    Theranostics; 2019; 9(24):7251-7267. PubMed ID: 31695766
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Screening Hub Genes as Prognostic Biomarkers of Hepatocellular Carcinoma by Bioinformatics Analysis.
    Zhou Z; Li Y; Hao H; Wang Y; Zhou Z; Wang Z; Chu X
    Cell Transplant; 2019 Dec; 28(1_suppl):76S-86S. PubMed ID: 31822116
    [TBL] [Abstract][Full Text] [Related]  

  • 15. MicroRNA-124-3p expression and its prospective functional pathways in hepatocellular carcinoma: A quantitative polymerase chain reaction, gene expression omnibus and bioinformatics study.
    He RQ; Yang X; Liang L; Chen G; Ma J
    Oncol Lett; 2018 Apr; 15(4):5517-5532. PubMed ID: 29552191
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Diagnostic value of strand-specific miRNA-101-3p and miRNA-101-5p for hepatocellular carcinoma and a bioinformatic analysis of their possible mechanism of action.
    Yang X; Pang YY; He RQ; Lin P; Cen JM; Yang H; Ma J; Chen G
    FEBS Open Bio; 2018 Jan; 8(1):64-84. PubMed ID: 29321958
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Identification of Potential Diagnostic and Prognostic Pseudogenes in Hepatocellular Carcinoma Based on Pseudogene-miRNA-mRNA Competitive Network.
    Yan L; Yue C; Xu Y; Jiang X; Zhang L; Wu J
    Med Sci Monit; 2020 May; 26():e921895. PubMed ID: 32457285
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Identification of key candidate genes and pathways in hepatocellular carcinoma by integrated bioinformatical analysis.
    Xing T; Yan T; Zhou Q
    Exp Ther Med; 2018 Jun; 15(6):4932-4942. PubMed ID: 29805517
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comprehensive network analysis of the molecular mechanisms associated with sorafenib resistance in hepatocellular carcinoma.
    Lin H; Zhang R; Wu W; Lei L
    Cancer Genet; 2020 Jul; 245():27-34. PubMed ID: 32559715
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Identification of Key Genes and Prognostic Value Analysis in Hepatocellular Carcinoma by Integrated Bioinformatics Analysis.
    Wang M; Wang L; Wu S; Zhou D; Wang X
    Int J Genomics; 2019; 2019():3518378. PubMed ID: 31886163
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.